Otonomy Board Approves Plan to Liquidate, Dissolve

Dow Jones
2022/12/20

By Denny Jacob

 

Otonomy Inc. on Monday said its board approved and adopted a plan to liquidate and dissolve its operations.

The plan, which is subject to shareholder approval, includes distributing remaining cash to shareholders after operations wind down, as well as proceeds from the sale of any pipeline assets, which it says is currently in discussions.

The biopharmaceutical company said it terminated all its employees, including officers, as part of the planned dissolution, effective last Thursday. David Weber continues to serve on the board and Paul Cayer continues to serve on a consulting basis as chief financial and business officer, as well as being appointed president. Otonomy said it expects to incur charges around $5 million for severance and other employee-termination related costs in the fourth quarter.

Otonomy said its board approved its plan last Tuesday. It intends to call a special shareholder meeting in the first quarter to seek approval for the plan and said it will file proxy materials with the Securities and Exchange Commission as soon as practicable.

 

Write to Denny Jacob at denny.jacob@wsj.com

 

(END) Dow Jones Newswires

December 19, 2022 17:21 ET (22:21 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10